Efektifitas Pemberian Proton Pump Inhibitor pada Bayi dan Anak dengan Laringomalasia

Riza Sahyuni; Bambang Supriyatno; Syahrial M Hutauruk; Aria Kekalih

doi:10.14238/sp18.6.2017.459-67

Efektifitas Pemberian Proton Pump Inhibitor pada Bayi dan Anak dengan Laringomalasia

Riza Sahyuni, Bambang Supriyatno, Syahrial M Hutauruk, Aria Kekalih

Research output: Contribution to journal › Article › peer-review

Abstract

laryngomalacia is condition of floopy supraglottis stucture and it causes symptom stridor. In general, the comorbidity of laryngomalacia is laryngopharyngeal reflux (LPR). The giving of omeperazole can improve the symptom of regurgitation and stridor and shorten the duration of natural disease of laryngomalacia. Objective. Knowing the effectivity of giving omeperazole to the babies and children with laryngomalacia. Method. Test pre-post experimental on 42 samples that have been given omeperazole 2x2 mg/kg/bw for 3 month. Result. Giving omeperazol on laryngomalacia with severe symptom showed the improvement of 58,8%. Giving omeperazole on laryngomalacia with RLF positive showed the improvement of 58,3%. Seemed statistically significant improvement in comparison pre and post score reflux finding score (RFS) and laringomalacia score symptom (LSS). Conclusion. The Prevalence of positive LPR based on RFS is 24,6% and with severe symptom is 44,6%. The effectivity of giving omeperazole for 3 month has proved effective based on the improvement of value LSS, RFS and nutrition status.

Original language	Indonesian
Pages (from-to)	459-467
Journal	Sari Pediatri
Volume	18
Issue number	6
DOIs	https://doi.org/10.14238/sp18.6.2017.459-67
Publication status	Published - 1 Apr 2017

Keywords

laryngopharyngeal reflux (LPR), reflux finding score (RFS), laryngomalacia symptom score (LSS), laryngomalacia

Access to Document

10.14238/sp18.6.2017.459-67Licence: CC BY-NC-SA

https://saripediatri.org/index.php/sari-pediatri/article/view/1092Licence: CC BY-NC-SA

Cite this

@article{fecdb54d5d86410181a749ea2bae1e91,

title = "Efektifitas Pemberian Proton Pump Inhibitor pada Bayi dan Anak dengan Laringomalasia",

abstract = "laryngomalacia is condition of floopy supraglottis stucture and it causes symptom stridor. In general, the comorbidity of laryngomalacia is laryngopharyngeal reflux (LPR). The giving of omeperazole can improve the symptom of regurgitation and stridor and shorten the duration of natural disease of laryngomalacia. Objective. Knowing the effectivity of giving omeperazole to the babies and children with laryngomalacia. Method. Test pre-post experimental on 42 samples that have been given omeperazole 2x2 mg/kg/bw for 3 month. Result. Giving omeperazol on laryngomalacia with severe symptom showed the improvement of 58,8%. Giving omeperazole on laryngomalacia with RLF positive showed the improvement of 58,3%. Seemed statistically significant improvement in comparison pre and post score reflux finding score (RFS) and laringomalacia score symptom (LSS). Conclusion. The Prevalence of positive LPR based on RFS is 24,6% and with severe symptom is 44,6%. The effectivity of giving omeperazole for 3 month has proved effective based on the improvement of value LSS, RFS and nutrition status.",

keywords = "laryngopharyngeal reflux (LPR), reflux finding score (RFS), laryngomalacia symptom score (LSS), laryngomalacia",

author = "Riza Sahyuni and Bambang Supriyatno and Hutauruk, {Syahrial M} and Aria Kekalih",

year = "2017",

month = apr,

day = "1",

doi = "10.14238/sp18.6.2017.459-67",

language = "Indonesian",

volume = "18",

pages = "459--467",

journal = "Sari Pediatri",

number = "6",

}

TY - JOUR

T1 - Efektifitas Pemberian Proton Pump Inhibitor pada Bayi dan Anak dengan Laringomalasia

AU - Sahyuni, Riza

AU - Supriyatno, Bambang

AU - Hutauruk, Syahrial M

AU - Kekalih, Aria

PY - 2017/4/1

Y1 - 2017/4/1

N2 - laryngomalacia is condition of floopy supraglottis stucture and it causes symptom stridor. In general, the comorbidity of laryngomalacia is laryngopharyngeal reflux (LPR). The giving of omeperazole can improve the symptom of regurgitation and stridor and shorten the duration of natural disease of laryngomalacia. Objective. Knowing the effectivity of giving omeperazole to the babies and children with laryngomalacia. Method. Test pre-post experimental on 42 samples that have been given omeperazole 2x2 mg/kg/bw for 3 month. Result. Giving omeperazol on laryngomalacia with severe symptom showed the improvement of 58,8%. Giving omeperazole on laryngomalacia with RLF positive showed the improvement of 58,3%. Seemed statistically significant improvement in comparison pre and post score reflux finding score (RFS) and laringomalacia score symptom (LSS). Conclusion. The Prevalence of positive LPR based on RFS is 24,6% and with severe symptom is 44,6%. The effectivity of giving omeperazole for 3 month has proved effective based on the improvement of value LSS, RFS and nutrition status.

AB - laryngomalacia is condition of floopy supraglottis stucture and it causes symptom stridor. In general, the comorbidity of laryngomalacia is laryngopharyngeal reflux (LPR). The giving of omeperazole can improve the symptom of regurgitation and stridor and shorten the duration of natural disease of laryngomalacia. Objective. Knowing the effectivity of giving omeperazole to the babies and children with laryngomalacia. Method. Test pre-post experimental on 42 samples that have been given omeperazole 2x2 mg/kg/bw for 3 month. Result. Giving omeperazol on laryngomalacia with severe symptom showed the improvement of 58,8%. Giving omeperazole on laryngomalacia with RLF positive showed the improvement of 58,3%. Seemed statistically significant improvement in comparison pre and post score reflux finding score (RFS) and laringomalacia score symptom (LSS). Conclusion. The Prevalence of positive LPR based on RFS is 24,6% and with severe symptom is 44,6%. The effectivity of giving omeperazole for 3 month has proved effective based on the improvement of value LSS, RFS and nutrition status.

KW - laryngopharyngeal reflux (LPR), reflux finding score (RFS), laryngomalacia symptom score (LSS), laryngomalacia

U2 - 10.14238/sp18.6.2017.459-67

DO - 10.14238/sp18.6.2017.459-67

M3 - Article

VL - 18

SP - 459

EP - 467

JO - Sari Pediatri

JF - Sari Pediatri

IS - 6

ER -